Showing results (71-80 of 115) with videos related to
Sort By:
Pageof 12
Vaccine|December 25, 2017
Mannitol treatment is not effective in therapy of rabies virus infection in miceLucie Dufkova, Jana Sirmarova, Jiri Salat, et al.Scientific Reports|August 20, 2022
Evaluation of the anti-SARS-CoV-2 properties of essential oils and aromatic extractsDaniel Jan Strub, Michał Talma, Maria Strub, et al.Journal of Medical Virology|March 1, 2022
Development and optimization of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: Evaluation of 5676 Phase 1 Passed StructuresWinston Chiu, Lore Verschueren, Christel Van den Eynde, et al.Journal of Molecular Structure|September 14, 2022
Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivativesAz-Eddine El Mansouri, Saida Lachhab, Ali Oubella, et al.Molecules (Basel, Switzerland)|January 8, 2023
Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp InhibitorsShenghua Gao, Letian Song, Hongtao Xu, et al.Antiviral Research|September 8, 2020
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometryZachary A Gurard-Levin, Cheng Liu, Andreas Jekle, et al.Journal of Medicinal Chemistry|April 19, 2021
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2Wenhao Dai, Dirk Jochmans, Hang Xie, et al.Antiviral Research|June 17, 2017
Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1Alba Gigante, Asier Gómez-SanJuan, Leen Delang, et al.The Journal of Antimicrobial Chemotherapy|June 22, 2014
Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviralLeen Delang, Nidya Segura Guerrero, Ali Tas, et al.Journal of Medicinal Chemistry|January 16, 2025
Structure-Based Optimization of Pyridone α-Ketoamides as Inhibitors of the SARS-CoV-2 Main ProteaseRavi Kumar Akula, Haifa El Kilani, Alina Metzen, et al.Pageof 12